Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

120 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Transdermal iontophoresis revisited.
Panchagnula R, Pillai O, Nair VB, Ramarao P. Panchagnula R, et al. Curr Opin Chem Biol. 2000 Aug;4(4):468-73. doi: 10.1016/s1367-5931(00)00111-3. Curr Opin Chem Biol. 2000. PMID: 10959777 Review.
In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles.
Dhanikula AB, Singh DR, Panchagnula R. Dhanikula AB, et al. Among authors: panchagnula r. Curr Drug Deliv. 2005 Jan;2(1):35-44. doi: 10.2174/1567201052772852. Curr Drug Deliv. 2005. PMID: 16305406
A highest plasma concentration following intravenous administration of paclitaxel was observed for rigid and 'Stealth((R))' liposomes containing the prodrug while, least was for covalently incorporated paclitaxel micelles. ...In tissue distribution studies, maximum percent …
A highest plasma concentration following intravenous administration of paclitaxel was observed for rigid and 'Stealth((R))' liposomes …
Single and multiple dose pharmacokinetic evaluation of a transdermal delivery system of imipramine hydrochloride.
Panchagnula R, Dravid P, Jain A, Khandavilli S. Panchagnula R, et al. Arzneimittelforschung. 2005;55(4):198-204. doi: 10.1055/s-0031-1296845. Arzneimittelforschung. 2005. PMID: 15901042
Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
Panchagnula R, Bokalial R, Sharma P, Khandavilli S. Panchagnula R, et al. Int J Pharm. 2005 Apr 11;293(1-2):213-23. doi: 10.1016/j.ijpharm.2005.01.004. Int J Pharm. 2005. PMID: 15778059
Preparation and characterization of water-soluble prodrug, liposomes and micelles of Paclitaxel.
Dhanikula AB, Panchagnula R. Dhanikula AB, et al. Among authors: panchagnula r. Curr Drug Deliv. 2005 Jan;2(1):75-91. doi: 10.2174/1567201052772861. Curr Drug Deliv. 2005. PMID: 16305410
Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
Panchagnula R, Desu H, Jain A, Khandavilli S. Panchagnula R, et al. Farmaco. 2005 Nov-Dec;60(11-12):894-9. doi: 10.1016/j.farmac.2005.07.004. Epub 2005 Aug 26. Farmaco. 2005. PMID: 16126203
RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulation.
Panchagnula R, Sharma P, Khandavilli S, Varma MV. Panchagnula R, et al. Farmaco. 2004 Oct;59(10):839-42. doi: 10.1016/j.farmac.2004.06.002. Farmaco. 2004. PMID: 15474062
Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel.
Panchagnula R, Desu H, Jain A, Khandavilli S. Panchagnula R, et al. J Pharm Sci. 2004 Sep;93(9):2177-83. doi: 10.1002/jps.20140. J Pharm Sci. 2004. PMID: 15295779
Influence of electrical parameters in the iontophoretic delivery of a small peptide: in vitro studies using arginine-vasopressin as a model peptide.
Nair VB, Panchagnula R. Nair VB, et al. Among authors: panchagnula r. Farmaco. 2004 Jul;59(7):583-93. doi: 10.1016/j.farmac.2004.02.001. Farmaco. 2004. PMID: 15231436
The effect of pretreatment with terpenes on transdermal iontophoretic delivery of arginine vasopressin.
Nair VB, Panchagnula R. Nair VB, et al. Among authors: panchagnula r. Farmaco. 2004 Jul;59(7):575-81. doi: 10.1016/j.farmac.2004.02.004. Farmaco. 2004. PMID: 15231435
120 results
Jump to page
Feedback